Remdesvir option in oral form, Jubilant Pharma seeks regulator nod | Editorji
  1. home
  2. > national
  3. > Remdesivir option in oral form, Jubilant Pharma seeks regulator nod
prev iconnext button of playermute button of playermaximize icon
mute icontap to unmute
video play icon
00:00/00:00
prev iconplay paus iconnext iconmute iconmaximize icon
close_white icon

Remdesivir option in oral form, Jubilant Pharma seeks regulator nod

Apr 19, 2021 18:25 IST | By Editorji News Desk

Amidst acute shortage of Remdesivir across the nation Jubilant Pharma has developed an oral substitute for the anti-viral drug. The pharma major stated it has completed safety trials in animals and healthy human volunteers in India using a novel oral formulation of Remdesivir.  The proposed oral treatment is expected to be for five days.

Jubilant has now sought approval for additional studies for this oral formulation from the Drug Controller General of India (DCGI). Jubilant Pharma is one of the 7 companies in India who produce Remdesivir in partnership with Gilead. 


National